Evogene Ltd. (EVGN)
0.2901
+0.02
(+7.05%)
USD |
NASDAQ |
Nov 09, 16:00
0.2901
0.00 (0.00%)
After-Hours: 19:48
Evogene Enterprise Value : 5.476M for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 5.476M |
| November 05, 2026 | 6.269M |
| November 04, 2026 | 6.638M |
| November 03, 2026 | 6.680M |
| November 02, 2026 | 6.694M |
| October 30, 2026 | 6.878M |
| October 29, 2026 | 6.957M |
| October 28, 2026 | 6.876M |
| October 27, 2026 | 6.732M |
| October 26, 2026 | 6.816M |
| October 23, 2026 | 6.736M |
| October 22, 2026 | 6.896M |
| October 21, 2026 | 6.822M |
| October 20, 2026 | 6.838M |
| October 19, 2026 | 6.789M |
| October 16, 2026 | 7.036M |
| October 15, 2026 | 7.221M |
| October 14, 2026 | 6.945M |
| October 13, 2026 | 7.090M |
| October 12, 2026 | 7.040M |
| October 09, 2026 | 6.981M |
| October 08, 2026 | 7.202M |
| October 07, 2026 | 7.366M |
| October 06, 2026 | 7.543M |
| October 05, 2026 | 7.274M |
| Date | Value |
|---|---|
| October 02, 2026 | 7.561M |
| October 01, 2026 | 7.704M |
| September 30, 2026 | 7.183M |
| September 29, 2026 | 7.358M |
| September 28, 2026 | 6.952M |
| September 25, 2026 | 7.435M |
| September 24, 2026 | 7.547M |
| September 23, 2026 | 7.930M |
| September 22, 2026 | 8.488M |
| September 21, 2026 | 8.075M |
| September 18, 2026 | 8.562M |
| September 17, 2026 | 8.621M |
| September 16, 2026 | 8.519M |
| September 15, 2026 | 8.956M |
| September 14, 2026 | 8.506M |
| September 11, 2026 | 8.306M |
| September 10, 2026 | 8.313M |
| September 09, 2026 | 8.603M |
| September 08, 2026 | 8.679M |
| September 04, 2026 | 9.089M |
| September 03, 2026 | 9.185M |
| September 02, 2026 | 9.109M |
| September 01, 2026 | 8.857M |
| August 31, 2026 | 9.07M |
| August 28, 2026 | 9.247M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Compugen Ltd. | 63.38M |
| Pluri, Inc. | 46.05M |
| Scinai Immunotherapeutics Ltd. | 7.709M |
| CollPlant Biotechnologies Ltd. | 5.443M |
| Regentis Biomaterials Ltd. | 50.73M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.591M |
| Revenue (Quarterly) | 0.347M |
| Total Expenses (Quarterly) | 1.939M |
| EPS Diluted (Quarterly) | -0.1449 |
| Gross Profit Margin (Quarterly) | -2.31% |
| Profit Margin (Quarterly) | -458.5% |
| Earnings Yield | -314.5% |
| Normalized Earnings Yield | -314.44 |